Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

(2011) W Chua et al.   BRITISH JOURNAL OF CANCER

High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy

(2010) S. C. H. Kao et al.   CLINICAL CANCER RESEARCH

Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy

(2009) Yoji Kishi et al.   ANNALS OF SURGICAL ONCOLOGY

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03

(2009) Y Kishida et al.   BRITISH JOURNAL OF CANCER

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03

(2009) Satoshi Teramukai et al.   EUROPEAN JOURNAL OF CANCER

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer

(2008) Khaled M. Sarraf et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy

(2008) A.G. Pallis et al.   LUNG CANCER